Non-Viral Drug Delivery Systems Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Non-Viral Drug Delivery Systems Market is Segmented By Type of Molecule Delivered (Small Molecules, Biologics), By Type of Biologic Delivered (RNAi/mRNA, DNA Oligonucleotides, Antibodies, Proteins/Peptides), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Competitive overview of Non-Viral Drug Delivery Systems Market
The major players operating in the non-viral drug delivery systems market include Arcturus Therapeutics, Bio-Path Holdings, CureVac, Entos Pharmaceuticals, eTheRNA Immunotherapies, Matinas BioPharma, MDimune and PCI Biotech.
Non-Viral Drug Delivery Systems Market Leaders
- Arcturus Therapeutics
- Bio-Path Holdings
- CureVac
- Entos Pharmaceuticals
- eTheRNA Immunotherapies
*Disclaimer: Major players are listed in no particular order.
Non-Viral Drug Delivery Systems Market - Competitive Rivalry, 2023
Non-Viral Drug Delivery Systems Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights